Lab Vision Corporation: Medical Device Recalls in 2016

Updated on March 25, 2026.

According to to data from the FDA, there was 1 medical device recall made by Lab Vision Corporation in 2016. See the detail of the recall below.

You can see similar recalls for other firms.

Data Source: FDA.

See this for other years:

CEA / CD66e Ab-2, Product code RB-368-R7, RB-368-R1; 7 ml each. Description Carcinoembryonic antigen (CEA), is synthesized during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is reportedly useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). This product is intended for qualitative immunohistochemistry with normal and neoplastic formalin-fixed, paraffin-embedded tissue sections, to be viewed by light microscopy.